US

Charles C-Y Shih

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles C-Y Shih. Retrieved from https://idiyas.com/inventor/charles-c-y-shih-isuukeqw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: The Innovations of Charles C-Y Shih

Introduction

Charles C-Y Shih is an accomplished inventor based in the United States. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have potential therapeutic applications. His work focuses on innovative solutions for treating serious health conditions.

Latest Patents

One of his notable inventions is related to 1,5-Diphenyl-Penta-1,4-Dien-3-One Compounds. This invention pertains to a compound with a 1,5-diphenylpenta-1,4-dien-3-one backbone, which has the ability to deactivate STAT proteins. These compounds are particularly useful in the treatment of cancer, inflammatory diseases, and autoimmune diseases. Although he currently holds no patents, his research is promising and could lead to significant advancements in medical treatments.

Career Highlights

Charles C-Y Shih is associated with Allianz Pharmascience Ltd., where he continues to explore innovative approaches in pharmaceutical development. His work is characterized by a commitment to improving health outcomes through scientific research and innovation.

Collaborations

He has collaborated with notable colleagues such as Toshio Kitamura and Qian Shi. These partnerships enhance the research environment and contribute to the advancement of their shared goals in medicinal chemistry.

Conclusion

Charles C-Y Shih is a dedicated inventor whose work in developing therapeutic compounds holds great promise for the future of medicine. His contributions to the field are noteworthy, and his ongoing research may lead to significant breakthroughs in treating various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…